Cancer Vaccines

It is presently evident that numerous human tumor antigens can be perceived by the safe framework. These tumor antigens can be characterized into a few gatherings including malignancy testis, separation, tissue particular, over-communicated, and viral-related antigens. Enhanced comprehension of the science of the insusceptible reaction, especially of safe acknowledgment and initiation of T-cells, permit better plan of antibodies.

  • Antibody-targeted fusion proteins for Cancer Therapy
  • Autoimmunity & Biotechnology
  • Clinical Laboratory Immunology
  • Immune-mediated Neurological Syndromes
  • Immunological aspects of Endocrine diseases & Chronic diseases
  • Immunological aspects of infection
  • Monoclonal antibodies and Organ Cancers
  • Tumor Immunology and Immunotherapy

Related Conference of Cancer Vaccines

February 27-28, 2025

8th International Conference on Vaccines and Immunology

Paris, France
April 10-11, 2025

5th International Conference on Vaccine Research

Dubai, UAE
April 22-23, 2025

8th International Conference on Vaccines, Immunology and Clinical Trials

Paris, France
April 28-29, 2025

2nd Global Summit on Vaccines & Emerging Diseases

Bali, Indonesia
May 05-06, 2025

45th Global Summit and Expo on Vaccines & Immunology

Rome, Italy
July 28-29, 2025

43rd Euro Global Summit and Expo on Vaccines & Vaccination

Aix-en-Provence, France
September 18-19, 2025

7th World Congress on Vaccine and Immunology

Amsterdam, Netherlands
October 06-07, 2025

37th Annual Congress on Vaccine and Clinical Trials

Vancouver, Canada

Cancer Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in